Explore
Validate
Learn
Western blot
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA041908 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA041908, RRID:AB_10794160
- Product name
- Anti-HN1L
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human HN1L, Gene description: hematological and neurological expressed 1-like, Alternative Gene Names: C16orf34, FLJ13092, KIAA1426, L11, Validated applications: WB, IHC, ICC, Uniprot ID: Q9H910, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.3 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Convergent activation of two-pore channels mediated by the NAADP-binding proteins JPT2 and LSM12
Convergent activation of Ca 2+ permeability in two-pore channel 2 through distinct molecular routes
HN1L/AP-2γ/PLK1 signaling drives tumor progression and chemotherapy resistance in esophageal squamous cell carcinoma
HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway
Overexpression of HN1L promotes cell malignant proliferation in non-small cell lung cancer
Gunaratne G, Brailoiu E, Kumar S, Yuan Y, Slama J, Walseth T, Patel S, Marchant J
Science Signaling 2023;16(799)
Science Signaling 2023;16(799)
Convergent activation of Ca 2+ permeability in two-pore channel 2 through distinct molecular routes
Saito R, Mu Q, Yuan Y, Rubio-Alarcón M, Eznarriaga M, Zhao P, Gunaratne G, Kumar S, Keller M, Bracher F, Grimm C, Brailoiu E, Marchant J, Rahman T, Patel S
Science Signaling 2023;16(799)
Science Signaling 2023;16(799)
HN1L/AP-2γ/PLK1 signaling drives tumor progression and chemotherapy resistance in esophageal squamous cell carcinoma
Zeng T, Deng T, Liu Z, Zhan J, Ma Y, Yan Y, Sun X, Zhu Y, Li Y, Guan X, Li L
Cell Death & Disease 2022;13(12)
Cell Death & Disease 2022;13(12)
HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway
Liu Y, Choi D, Sheng J, Ensor J, Liang D, Rodriguez-Aguayo C, Polley A, Benz S, Elemento O, Verma A, Cong Y, Wong H, Qian W, Li Z, Granados-Principal S, Lopez-Berestein G, Landis M, Rosato R, Dave B, Wong S, Marchetti D, Sood A, Chang J
Stem Cell Reports 2018;10(1):212-227
Stem Cell Reports 2018;10(1):212-227
Overexpression of HN1L promotes cell malignant proliferation in non-small cell lung cancer
Li L, Zeng T, Zhang B, Li Y, Zhu Y, Guan X
Cancer Biology & Therapy 2017;18(11):904-915
Cancer Biology & Therapy 2017;18(11):904-915
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescent staining of human cell line A-431 shows localization to plasma membrane & cytosol.
- Sample type
- Human
